We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANGI icon
3201
Angi Inc
ANGI
$191M
$92K ﹤0.01%
826
+762
+1,191% +$105K
AQST icon
3202
Aquestive Therapeutics
AQST
$527M
$92K ﹤0.01%
18,921
+17,938
+1,825% +$117K
BB icon
3203
BlackBerry
BB
$5.25B
$92K ﹤0.01%
20,201
+14,411
+249% +$69.8K
EOLS icon
3204
Evolus
EOLS
$536M
$92K ﹤0.01%
23,418
+16,604
+244% +$60.7K
IGMS
3205
DELISTED
IGM Biosciences
IGMS
$92K ﹤0.01%
1,254
-1,700
-58% -$101K
IMO icon
3206
Imperial Oil
IMO
$65.1B
$92K ﹤0.01%
7,745
+6,033
+352% +$94.6K
IPGP icon
3207
IPG Photonics
IPGP
$3.65B
$92K ﹤0.01%
543
-1,210
-69% -$200K
KPTI icon
3208
Karyopharm Therapeutics
KPTI
$45.3M
$92K ﹤0.01%
420
-401
-49% -$98.1K
GNOG
3209
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$92K ﹤0.01%
+6,399
New +$92.2K
AMH icon
3210
American Homes 4 Rent
AMH
$12.3B
$91K ﹤0.01%
3,201
+1,545
+93% +$43.6K
APLS
3211
DELISTED
Apellis Pharmaceuticals
APLS
$91K ﹤0.01%
3,005
-5,647
-65% -$169K
DAO
3212
Youdao
DAO
$2.17B
$91K ﹤0.01%
+3,505
New +$120K
EWC icon
3213
iShares MSCI Canada ETF
EWC
$6.55B
$91K ﹤0.01%
3,320
-1,523
-31% -$42.1K
EWN icon
3214
iShares MSCI Netherlands ETF
EWN
$736M
$91K ﹤0.01%
2,592
+1,536
+145% +$53.5K
FCCO icon
3215
First Community Corp
FCCO
$326M
$91K ﹤0.01%
6,686
-4,759
-42% -$65.1K
HEI.A icon
3216
HEICO Corp Class A
HEI.A
$38.1B
$91K ﹤0.01%
1,026
-952
-48% -$80.4K
UBSI icon
3217
United Bankshares
UBSI
$6.7B
$91K ﹤0.01%
4,257
-22,897
-84% -$596K
ICBK
3218
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$91K ﹤0.01%
4,851
-1,663
-26% -$32.3K
MDLA
3219
DELISTED
Medallia, Inc.
MDLA
$91K ﹤0.01%
3,308
-14,936
-82% -$453K
CEMI
3220
DELISTED
Chembio diagnostics, Inc.
CEMI
$91K ﹤0.01%
18,746
+16,630
+786% +$78.8K
MTL
3221
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$91K ﹤0.01%
60,489
-5,273
-8% -$8.91K
AXS icon
3222
AXIS Capital
AXS
$7.43B
$90K ﹤0.01%
2,037
-10,121
-83% -$441K
OVLY icon
3223
Oak Valley Bancorp
OVLY
$288M
$90K ﹤0.01%
7,795
+6,363
+444% +$82.8K
STR
3224
DELISTED
Sitio Royalties
STR
$90K ﹤0.01%
9,257
+8,487
+1,102% +$95.4K
TV icon
3225
Televisa
TV
$1.52B
$90K ﹤0.01%
14,445
-8,351
-37% -$50.9K
127 128
129
130 131

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.